高钙尿症
肾钙质沉着症
低磷血症
低磷血症性佝偻病
内分泌学
内科学
重吸收
骨软化症
肾单位
人口
肾小管病变
佝偻病
医学
肾
维生素D与神经学
排泄
环境卫生
作者
Ж. Г. Левиашвили,Н. Д. Савенкова,O. V. Lyubimova,N. L. Levi,M. O. Prokofeva,T. V. Karpova
出处
期刊:Нефрология
[Non-profit organization Nephrology]
日期:2021-04-23
卷期号:25 (3): 52-60
被引量:1
标识
DOI:10.36485/1561-6274-2021-25-3-52-60
摘要
Orphan Hereditary Hypophosphatemic Rickets with Hypercalciuria (HHRH) (OMIM: 241530; ORPHA: 157215) with an autosomal recessive mode of inheritance occurs with an estimated prevalence of 1: 250,000 in the child population. HHRH was first described by M. Tieder, et al. (1985). The syndrome is caused by heterozygous or homozygous mutations in the SLC34A3 gene mapped to chromosome 9q34.3, which encodes a type II sodium phosphate cotransporter (NaPiIIc). Mutations result in loss of NaPi-IIc function and impairment of phosphate reabsorption in the proximal renal nephron. HHRH is characterized by a decrease in phosphate reabsorption in the proximal nephron tubules, manifested by hyperphosphaturia, hypercalciuria, hypophosphatemia, an increase in the concentration of 1,25(OH) 2D3, a decrease in parathyroid hormone (PTH) circulating in the blood, osteomalacia, inhibition of growth, low corrosiveness, low corrosiveness. The article presents the characteristics of the phenotype and genotype of HHRH, diagnostic criteria and treatment strategy. A description of a clinical case of HHRH with hypercalciuria, nephrocalcinosis and urolithiasis due to mutation of the SLC34A3gene is presented.
科研通智能强力驱动
Strongly Powered by AbleSci AI